Scott Buttram

Title: Scott Buttram - Innovator in Antibody Labeling Technology

Introduction

Scott Buttram is a notable inventor based in Downingtown, PA (US). He has made significant contributions to the field of biomedical technology, particularly in the area of antibody labeling. His innovative approach has led to the development of a unique method that enhances the efficiency of labeling antibodies.

Latest Patents

Scott Buttram holds 1 patent for his invention titled "One vial method for labeling antibodies with Technetium-99m." This patent discloses a method for labeling a sulfhydryl containing antibody or antibody fragment with technetium-99m. The method involves contacting an antibody mixture, which includes a sulfhydryl containing antibody or antibody fragment and a reducing agent, with technetium-99m in an oxidized state. In a preferred embodiment, the antibody mixture also contains a water-soluble ligand. Additionally, a one vial kit for labeling a sulfhydryl containing antibody or antibody fragment with technetium-99m is disclosed.

Career Highlights

Scott Buttram has worked at Centocor, Inc., where he has applied his expertise in antibody technology. His work has contributed to advancements in medical imaging and therapeutic applications. His innovative methods have the potential to improve the accuracy and effectiveness of diagnostic procedures.

Collaborations

Scott has collaborated with notable colleagues, including Richard T Dean and John Lister-James. These collaborations have fostered a productive environment for innovation and development in the field of biomedical research.

Conclusion

Scott Buttram's contributions to antibody labeling technology exemplify the impact of innovation in the biomedical field. His patented method represents a significant advancement that could enhance medical diagnostics and treatment options.